Abiraterone Acetate for Adenocarcinoma Clinical Trial 2022 | Power
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - The Lancet Oncology
Roundtable Discussion: Morgans Addresses How PSA Levels Affect Nonmetastatic CRPC Treatment
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
International Braz J Urol ::
Summary of PSA Doubling Time and Velocity Definitions | Download Table
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time | American Society of Clinical Oncology Educational Book
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - ScienceDirect
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the place
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
International Braz J Urol ::
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy | HTML
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - ScienceDirect
Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinations - Urology
PSA Doubling Time Calculator
The PSA-doubling time in patients with different rate of prostate... | Download Table
Prostatic Specific Antigen for Prostate Cancer Detection
